Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XVIVO Perfusion AB
XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System
September 28, 2026
XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe
August 11, 2026
XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport
August 3, 2026
Interim Report January – June 2026
July 14, 2026
Conference call on Interim Report April-June 2026
June 26, 2026
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
April 27, 2026
Interim Report January – March 2026
April 24, 2026
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 22, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 22, 2026
Conference Call on Interim Report January-March 2026
April 17, 2026
1
2
Next Page
→